EDIT-B®
Blood test to differentiate unipolar depression from bipolar disorder
EDITOX®
Cell-based solutions to mimic drug impact on RNA editing
EDITECH®
Integrated platform from RNA / DNA sequencing to machine learning and AI
Meet us
26th Annual Conference of the International Society for Bipolar Disorders (ISBD)
29th September – 1st October 2024 in Reykjavik, Iceland
Come and meet us at ISBD 2024! Our CSO Dr. Dinah Weissmann will be giving a talk on “𝗔𝗜 𝗔𝗹𝗴𝗼𝗿𝗶𝘁𝗵𝗺 𝗖𝗼𝗺𝗯𝗶𝗻𝗲𝗱𝗪𝗶𝘁𝗵 𝗥𝗡𝗔 𝗘𝗱𝗶𝘁𝗶𝗻𝗴-𝗕𝗮𝘀𝗲𝗱 𝗕𝗹𝗼𝗼𝗱 𝗕𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿𝘀 𝘁𝗼 𝗗𝗶𝘀𝗰𝗿𝗶𝗺𝗶𝗻𝗮𝘁𝗲 𝗕𝗶𝗽𝗼𝗹𝗮𝗿 𝗙𝗿𝗼𝗺 𝗠𝗮𝗷𝗼𝗿 𝗗𝗲𝗽𝗿𝗲𝘀𝘀𝗶𝘃𝗲 𝗗𝗶𝘀𝗼𝗿𝗱𝗲𝗿𝘀” on Sunday, September 29th, from 5:30 pm GMT (oral session New & Trending Oral Session II).
Innovative Diagnostic Company
ALCEDIAG is an innovative diagnostic company specializing in the development and commercialization of blood tests, monitoring solutions, and companion diagnostics, primarily for mental health. These offerings are based upon the company’s distinctive expertise in epigenetics, RNA, and Artificial Intelligence, complemented by neurosciences and psychiatry.
ALCEDIAG’s unique approach is protected by seven patent families and supported by a global network of Key Opinion Leaders, who serve both as advocate for and early adopt of ALCEDIAG’s solutions.